Dearborn Partners’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,010
Closed -$317K 266
2025
Q2
$317K Buy
1,010
+10
+1% +$2.89K 0.02% 215
2025
Q1
$263K Hold
1,000
0.01% 225
2024
Q4
$261K Hold
1,000
0.01% 232
2024
Q3
$233K Hold
1,000
0.01% 251
2024
Q2
$202K Buy
+1,000
New +$180K 0.01% 252
2024
Q1
Sell
-1,000
Closed -$217K 269
2023
Q4
$217K Buy
+1,000
New +$172K 0.01% 250
2023
Q3
Sell
-1,000
Closed -$288K 249
2023
Q2
$288K Hold
1,000
0.01% 199
2023
Q1
$319K Hold
1,000
0.01% 181
2022
Q4
$294K Hold
1,000
0.01% 192
2022
Q3
$229K Hold
1,000
0.01% 231
2022
Q2
$218K Hold
1,000
0.01% 240
2022
Q1
$266K Hold
1,000
0.01% 237
2021
Q4
$266K Hold
1,000
0.01% 231
2021
Q3
$284K Hold
1,000
0.01% 206
2021
Q2
$275K Hold
1,000
0.01% 212
2021
Q1
$261K Hold
1,000
0.01% 216
2020
Q4
$256K Hold
1,000
0.01% 220
2020
Q3
$237K Buy
+1,000
New +$211K 0.01% 202

Other funds holding PODD

Dearborn Partners's PODD Position: Q3 2025 in Review

Dearborn Partners sold out of Insulet (PODD) in Q3 2025, closing a stake of 1,010 shares — an estimated $317K sold.

Dearborn Partners first reported a position in PODD in Q3 2020 and held it in 18 quarters. The position peaked at $319K in Q1 2023. 813 funds tracked by Wall St. Rank hold PODD as of Q3 2025.

  • Dearborn Partners reported no remaining Insulet position as of Q3 2025 after selling out during the quarter.
  • Dearborn Partners sold 1,010 Insulet shares in Q3 2025, an estimated $317K.
  • Dearborn Partners first reported a position in Insulet in Q3 2020 and held it in 18 quarters.
  • Dearborn Partners's Insulet position peaked at $319K in Q1 2023.
  • 813 funds tracked by Wall St. Rank held Insulet as of Q3 2025.

Based on Dearborn Partners's 13F filing for Q3 2025, filed 10 Nov 2025.